Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREFor the vaccination of healthy pregnant swine to provide passive immunity against rotaviral diarrhea, colibacillosis and enterotoxemia due to…
LEARN MORELearn more about this fast-acting pain relief solution for horses which is consistent, safe, and backed by Merck Animal Health.
LEARN MORETreatment for subclinical infectious bovine mastitis in lactating cows due to Streptococcus agalactiae and penicillin-sensitive Staphylococcus aureus.
LEARN MORE